These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14643578)

  • 1. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension.
    Lacourcière Y; Poirier L
    Am J Hypertens; 2003 Dec; 16(12):1036-42. PubMed ID: 14643578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
    Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.
    Pareek AK; Messerli FH; Chandurkar NB; Dharmadhikari SK; Godbole AV; Kshirsagar PP; Agarwal MA; Sharma KH; Mathur SL; Kumbla MM
    J Am Coll Cardiol; 2016 Feb; 67(4):379-389. PubMed ID: 26821625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.
    Cho EJ; Lee HY; Sung KC; Park S; Sohn IS; Park CG; Choi DJ; Ha JW; Ahn YK; Shin J; Hong SJ; Kim SK; Chung WJ; Yoo BS; Hong TJ; Youn HJ; Cho MC; Chae SC; Kim YJ; Kim CJ
    Am J Hypertens; 2019 Sep; 32(10):992-1002. PubMed ID: 31099387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
    Fukutomi M; Hoshide S; Eguchi K; Watanabe T; Kario K
    Am J Hypertens; 2013 Jun; 26(6):784-92. PubMed ID: 23446957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY; Ahn T; Bae JH; Lim DS; Lee SU; Kim YK; Hyon MS; Kim WH; Han KR; Park HK
    Clin Ther; 2014 Oct; 36(10):1402-11. PubMed ID: 25146365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension.
    Lacourcière Y; Poirier L; Lefebvre J
    Can J Cardiol; 2007 Apr; 23(5):377-82. PubMed ID: 17440643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
    Manolis AJ; Grossman E; Jelakovic B; Jacovides A; Bernhardi DC; Cabrera WJ; Watanabe LA; Barragan J; Matadamas N; Mendiola A; Woo KS; Zhu JR; Mejia AD; Bunt T; Dumortier T; Smith RD
    Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
    Radchenko GD; Sirenko YM; Kushnir SM; Torbas OO; Dobrokhod AS
    Vasc Health Risk Manag; 2013; 9():535-49. PubMed ID: 24109189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension.
    Minami J; Furukata S; Ishimitsu T; Matsuoka H
    Int Heart J; 2009 Jan; 50(1):85-93. PubMed ID: 19246849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours].
    Förster A; Smolka W; Jung C; Bestehorn K
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():111-8. PubMed ID: 17955788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertension.
    Neutel JM; Smith D
    J Int Med Res; 2005; 33(6):620-31. PubMed ID: 16372579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.